Gujarat Kidney And Super Speciality cash flow

Latest FY26
Cash from operations
−₹3.9cr 
Capital spending
₹10.8cr 
Free cash flow
−₹14.7cr 
Cash from financing
₹228cr 
₹ crore except per share
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026
Adjustments to reconcile profit — non-cash items
—4.7
—1.9
—−0.8
—0.4
Changes in working capital
—−1.4
—−23.5
—−4.4
—−0.9
—13.2
—5.2
—−13.1
—2.8
—0.1
Cash from operating activities
20.721.2
—−15.6
—5.6
—9.5
—−3.9
Cash from investing activities
—10.8
—6.4
—83.6
—12.0
—0.8
—−102
—−214
Cash from financing activities
—251
—0.2
—12.2
—0.4
—−1.2
—1.9
—−33.3
—228
—10.7
—10.7
Reference items
26.726.9
26.4%32.9%
−14.7−14.7
−₹1.86−₹1.86
—−0.23×
—9.5
—1.9
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

GKSL₹171.87

Gujarat Kidney And Super Speciality Limited

· Pharma & Health
₹ CrorePeersGPTHEALTHSHALBYINDRAMEDCOLOTUSEYEARTEMISMEDDRAGARWQKMCSHILKOVAIMcap ₹1,355 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation4.7—
+ Finance Costs1.9—
+ Interest Income-0.8—
+ Other Non-cash Items0.4—
Changes in Working Capital
+ Inventories-1.4—
+ Trade Receivables — Current-23.5—
+ Other Financial Assets — Current-4.4—
+ Other Current Assets-0.9—
+ Other Non-current Assets13.2—
+ Trade Payables — Current5.2—
+ Other Financial Liabilities — Current-13.1—
+ Other Current Liabilities2.8—
+ Provisions — Current0.1—
Cash from Operating Activities
Profit Before Tax (per I/S)21.220.7
+ Total Adjustments (incl. Working Capital)-15.6—
Cash from Operations (pre-tax)5.6—
+ Income Taxes Paid9.5—
Cash from Operating Activities-3.9—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)10.8—
+ Acq of Investment Property6.4—
+ Acq of Goodwill83.6—
+ Investment in Partnership Firms / LLPs12.0—
+ Interest Received — Investing0.8—
+ Other Inflows / (Outflows) — Investing-101.8—
Cash from Investing Activities-213.9—
Cash from Financing Activities
+ Proceeds from Issue of Shares250.8—
+ Payments — Change in Ownership of Subsidiaries0.2—
+ Proceeds from Borrowings12.2—
+ Repayment of Borrowings0.4—
+ Payment of Lease Liabilities-1.2—
+ Interest Paid1.9—
+ Other Inflows / (Outflows) — Financing-33.3—
Cash from Financing Activities228.4—
Net Changes in Cash (pre-FX)10.7—
Net Changes in Cash10.7—
Reference Items
EBITDA26.926.7
EBITDA Margin %32.8526.42
Free Cash Flow (CFO − Capex)-14.7-14.7
Free Cash Flow per Basic Share-1.86-1.86
Cash Flow to Net Income-0.23—
Cash Paid for Taxes9.5—
Cash Paid for Interest1.9—
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.